| pubmed-article:203227 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:203227 | lifeskim:mentions | umls-concept:C0014644 | lld:lifeskim |
| pubmed-article:203227 | lifeskim:mentions | umls-concept:C0009450 | lld:lifeskim |
| pubmed-article:203227 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:203227 | lifeskim:mentions | umls-concept:C1550587 | lld:lifeskim |
| pubmed-article:203227 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:203227 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:203227 | pubmed:dateCreated | 1978-3-21 | lld:pubmed |
| pubmed-article:203227 | pubmed:abstractText | Infectious Epstein-Barr virus (EBV) was produced from suspension cultures of P3HR-1 cells. A protocol for the scaled-up production and concentration of the virus was developed. Virus from the culture fluid was concentrated by continuous-flow pelletization or continuous flow with banding in sucrose. EBV prepared by pelletization yielded 1.7 X 10(4) infectious units/ml (100 X concentration) and less than 3.4 X 10(7) EVB particles/ml (1,000 X concentration), whereas EBV prepared by banding yielded 4.6 X 10(3) infectious units/ml (100 X concentration) aand 1.3 X 10(8) EBV particles 1 ml (1,000 X concentration). The majority of the virus particles observed were "empty" membrane-associated particles. A statistical test of the correlation between infectivity and virus particle count was made. | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:language | eng | lld:pubmed |
| pubmed-article:203227 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:203227 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:203227 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:203227 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:203227 | pubmed:issn | 0099-2240 | lld:pubmed |
| pubmed-article:203227 | pubmed:author | pubmed-author:KleinFF | lld:pubmed |
| pubmed-article:203227 | pubmed:author | pubmed-author:HillmanE AEA | lld:pubmed |
| pubmed-article:203227 | pubmed:author | pubmed-author:RosensteelJ... | lld:pubmed |
| pubmed-article:203227 | pubmed:author | pubmed-author:RiggsC WCW | lld:pubmed |
| pubmed-article:203227 | pubmed:author | pubmed-author:HummerR MRM | lld:pubmed |
| pubmed-article:203227 | pubmed:author | pubmed-author:CharmellaL... | lld:pubmed |
| pubmed-article:203227 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:203227 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:203227 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:203227 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:203227 | pubmed:pagination | 172-8 | lld:pubmed |
| pubmed-article:203227 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:203227 | pubmed:meshHeading | pubmed-meshheading:203227-C... | lld:pubmed |
| pubmed-article:203227 | pubmed:meshHeading | pubmed-meshheading:203227-V... | lld:pubmed |
| pubmed-article:203227 | pubmed:meshHeading | pubmed-meshheading:203227-V... | lld:pubmed |
| pubmed-article:203227 | pubmed:meshHeading | pubmed-meshheading:203227-C... | lld:pubmed |
| pubmed-article:203227 | pubmed:meshHeading | pubmed-meshheading:203227-H... | lld:pubmed |
| pubmed-article:203227 | pubmed:year | 1978 | lld:pubmed |
| pubmed-article:203227 | pubmed:articleTitle | Large-scale production and concentration of infectious Epstein-Barr virus. | lld:pubmed |
| pubmed-article:203227 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:203227 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:203227 | lld:pubmed |
